INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

21,588 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$29K
5,967 sh
Apr 2, 2026Apr 6, 2026
Page 342 of 540
← PrevNext →
traded Apr 2, 2026
+4d
SEC Form 4

Evidence

36
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$9,226
1,879 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

34
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$3.21M
21.4K sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

32
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$1,268
251 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

32
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$3,923
799 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

32
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$515
102 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

32
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,468
1,521 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

32
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$2,651
525 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

32
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$8,666
1,716 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

24
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale
SELL$14K
766 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

24
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Open-market sale
SELL$116K
5,566 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

24
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale
SELL$12K
692 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

24
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale
SELL$21K
1,181 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

24
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale
SELL$18K
1,010 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

23
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$138K
38.0K sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

23
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$254K
1,692 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.73M
1.00M sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

21
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$120K
24.9K sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

21
UJ
Uczekaj JohnDirector, President and COO
AIROAIRO Group Holdings, Inc.
Open-market sale
SELL$30K
3,415 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

21
CK
Connors Michele KimGeneral Counsel
AMBQAmbiq Micro, Inc.
Open-market sale
SELL$4,024
151 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

21
CK
Connors Michele KimGeneral Counsel
AMBQAmbiq Micro, Inc.
Open-market sale
SELL$17K
660 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$5,661
265 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
PM
Pauls MatthewDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$7,926
371 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$6,010
293 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$8,053
377 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
PM
Pauls MatthewDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$8,514
415 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$8,616
420 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
MR
Malamut RichardDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$5,981
280 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
MR
Malamut RichardDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$6,359
310 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

20
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$5,097
1,038 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,678
333 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$187
37 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

16
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$25K
10.0K sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

16
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.69M
1.00M sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

13
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$24K
10.0K sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
1,552 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC Form 4

Evidence

11
CM
Chaouki Steven MPresident, US Markets
TRUTransUnion
Open-market sale · 10b5-1 plan
SELL$350K
5,000 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

8
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
1,931 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

8
GS
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
829 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence

8
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$16K
893 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC Form 4

Evidence